A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 150
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AP-2
Long Form : activator protein-2
No. Year Title Co-occurring Abbreviation
1987 Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. hMT-IIA
1989 cAMP-dependent binding of a trans-acting factor to the thyroglobulin promoter. CRE, Tg
1989 Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. HBV, HIV-1
1990 A putative AP-2 binding site in the 5' flanking region of the mouse POMC gene. ---
1990 Structural characterization of the human DNA topoisomerase I gene promoter. CAT
1991 Interactions between adenovirus E1A and members of the AP-1 family of cellular transcription factors. AP-1, CRE, NE, NF1
1992 Identification and characterization of the GC-rich and cyclic adenosine 3',5'-monophosphate (cAMP)-inducible promoter of the type II beta cAMP-dependent protein kinase regulatory subunit gene. cAMP, CAT
1992 Structural characterization of the 5' regions of the human phenylalanine hydroxylase gene. CREs, GREs, PAH, PKU
1993 Is an activator protein-2-like transcription factor involved in regulating gene expression during nitrogen limitation in fungi? ---
10  1993 Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. NF1, TGF-beta
11  1994 Genomic structure of human adrenomedullin gene. AM
12  1994 Promoter function of the human glucose-6-phosphate dehydrogenase gene depends on two GC boxes that are cell specifically controlled. Sp1
13  1995 Characterization of 5' end of human thromboxane receptor gene. Organizational analysis and mapping of protein kinase C--responsive elements regulating expression in platelets. CAT
14  1995 Differential activation of heat-shock and oxidation-specific stress genes in chemically induced oxidative stress. ---
15  1995 Genomic organization and promoter sequence of a gene encoding a rat liver-specific type-I transport protein. PPRE
16  1996 Alterations in transcription factor-binding activities to fibronectin promoter during aging of vascular endothelial cells. CRE, CTF, FN, Sp-1, TFIID
17  1996 Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. ---
18  1997 Conserved elements in the 5' regulatory region of the amyloid precursor protein gene in primates. AP-1, APOE-B1, APP, HSE, IE1, PCR
19  1997 Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family. ---
20  1997 Positive and negative regulation of the rat vasopressin gene promoter. CRE, CREB, GR
21  1997 Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor. AP-1, bFGF
22  1997 Regulation of tPA in endothelial cells exposed to cyclic strain: role of CRE, AP-2, and SSRE binding sites. CRE, EC, SSRE, tPA
23  1997 Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter. BSP, NF1, TAE, TGF-beta
24  1998 A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity. CHO
25  1998 Both the cyclic AMP response element and the activator protein 2 binding site mediate basal and cyclic AMP-induced transcription from the dominant promoter of the rat alpha 1B-adrenergic receptor gene in DDT1MF-2 cells. alpha 1BAR, CRE
26  1998 Effect of in vivo administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on DNA-binding activities of nuclear transcription factors in liver of guinea pigs. AP-1, CRE, EMSA, RE, Sp1, TCDD
27  1998 Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. AM, HAEC, NF-IL6
28  1998 Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter. CRE, CREB, CREM, PMA, Sp-1, tPA
29  1999 Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences. C/EBP, IGF, NF1
30  1999 Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. OF5
31  1999 AP-2 (activating protein 2) and Sp1 (selective promoter factor 1) regulatory elements play distinct roles in the control of basal activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human chorionic gonadotropin-beta promoter. CGbeta, LHbeta
32  1999 Characterization of the human very-long-chain acyl-CoA dehydrogenase gene promoter region: a role for activator protein 2. FAO, VLCAD, VLCAD-Luc
33  1999 Distribution of AP-2 subtypes in the adult mouse brain. CNS, mRNA
34  1999 Dual activity of pyrrolidine dithiocarbamate on kappa B-dependent gene expression in U937 cells: I. Regulation by the phorbol ester TPA. NF-kappaB, PDTC, TPA
35  1999 Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. C/EBP, COX-2, cPLA2, CREB, IL-4, NF-kappaB, OA, PGE2, sTNFR, TNF-alpha, TNFR
36  1999 Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity. bHLH, C/EBP, HNF-3, Inr
37  1999 Molecular cloning and sequence analysis of the 5'-flanking region of the Sprague-Dawley rat thrombomodulin gene. AP-1, PCR, RARE, SP1, TNF-alpha
38  1999 Platelet-derived growth factor-BB inhibits rat alpha1D-adrenergic receptor gene expression in vascular smooth muscle cells by inducing AP-2-like protein binding to alpha1D proximal promoter region. bp, PDGF, SMC
39  2000 Activator protein-2 regulates human placental lactogen gene expression. hGH, hPL-A, NFI
40  2000 Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation. ---
41  2000 Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. EH, NP, NT
42  2000 Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia. PCR, SSCP
43  2000 Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. NGFI-A, PKA, PTU
44  2000 Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin beta promoter. hCG-beta, PKA
45  2000 Transcriptional control of adrenomedullin induction by phorbol ester in human monocytic leukemia cells. TPA
46  2000 Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes. CAT, NHK
47  2000 Transcriptional regulation of 2',3'-cyclic nucleotide 3'-phosphodiesterase gene expression by cyclic AMP in C6 cells. cAMP
48  2001 Cloning and functional analysis of SEL1L promoter region, a pancreas-specific gene. ---
49  2001 Constitutive activation of transcription factor AP-2 is associated with decreased MnSOD expression in transformed human lung fibroblasts. MnSOD, SOD2
50  2001 Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. ERK/MAPK, MMP-2
51  2001 Functional characterization of the basal promoter of the murine LH receptor gene in immortalized mouse Leydig tumor cells. bp, LHR
52  2001 Induction of transcription factor AP-2 by cytokines and prostaglandins in cultured mesangial cells. ---
53  2001 Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat. AP-1, CREB
54  2001 Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene. oPL
55  2001 Transcriptional regulation of human placental leucine aminopeptidase/oxytocinase gene. P-LAP
56  2001 UVA-340 as energy source, mimicking natural sunlight, activates the transcription factor AP-1 in cultured fibroblasts: evidence for involvement of protein kinase-C. AP-1, NF-kappaB, UVR
57  2002 Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain. ---
58  2002 Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. ---
59  2002 Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Sp1, VEGF
60  2002 Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. ---
61  2002 Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line. COX-2, NF-IL6
62  2002 Modulation of the human protein kinase C alpha gene promoter by activator protein-2. GBM, PKCalpha
63  2002 No association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia. AP-2beta
64  2002 Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. AP-1, EMSA, MMP, NF-kappaB, PEA-3, RT-PCR
65  2002 Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. BCRS, RFS
66  2002 Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3. ---
67  2002 Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). AP, MnSOD, Sp1
68  2003 Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region. 5'-UTR, AP-2gamma, ERalpha
69  2003 AP-2 and HNK-1 define distinct populations of cranial neural crest cells. CNCC
70  2003 Associations of a polymorphic AP-2 binding site in the 5'-flanking region of the bovine beta-lactoglobulin gene with milk proteins. beta-LG, HF, SM, SNP
71  2003 Binding of AP-2 and ETS-domain family members is associated with enhancer activity in the hypersensitive site III region of the human growth hormone/chorionic somatomammotropin locus. AP
72  2003 Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells. AP-2gamma
73  2003 Cloning and characterization of porcine common gamma chain gene. IL-2R, NK, RH, TCF-1
74  2003 Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha. AD, PC4, PC4, ss
75  2003 GCF2: expression and molecular analysis of repression. EGFR, FISH, GCF2
76  2003 Kinetics of lipopolysaccharide-induced transcription factor activation/inactivation and relation to proinflammatory gene expression in the murine spleen. AP-1, C/EBP, CRE, EMSA, IL, LPS, NF-kappaB, Sp1, TNF-alpha
77  2003 Mitochondrial cytochrome c release mediates ceramide-induced activator protein 2 activation and gene expression in keratinocytes. cyt c, ICAM-1
78  2003 p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. BCRS, PR, RFS
79  2003 Phenelzine treatment increases transcription factor AP-2 levels in rat brain. MAO, NA, PLZ, TCA
80  2003 Placental leucine aminopeptidase/oxytocinase gene regulation by activator protein-2 in BeWo cell model of human trophoblast differentiation. FSK, P-LAP
81  2003 Positive influence of AP-2alpha transcription factor on cadherin gene expression and differentiation of the ocular surface. ---
82  2003 Variations of human adrenomedullin gene and its relation to cardiovascular diseases. AM, CA, HIF-1, NF-IL6
83  2003 [The study on the interleukin-8 (IL-8)]. AP-1, HNF1, IL-8, IL-8R, IRF-1
84  2004 Differential expression of activator protein-2 isoforms in renal cell carcinoma. RCC
85  2004 Expression of HER2 and its association with AP-2 in breast cancer. BCRS, CISH, HER2, IHC, RFS
86  2004 Involvement of AP-2 binding sites in regulation of human beta-glucuronidase. ---
87  2004 Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter. MnSOD
88  2004 Regulation of sphingosine kinase 1 gene expression by protein kinase C in a human leukemia cell line, MEG-O1. EMSA, PKC, PMA, Sp1, SphK
89  2004 Requirement for proximal putative Sp1 and AP-2 cis-deoxyribonucleic acid elements in mediating basal and luteinizing hormone- and insulin-dependent in vitro transcriptional activation of the CYP17 gene in porcine theca cells. CYP17, Sp1
90  2004 Transcriptional regulation of the human chorionic gonadotropin beta gene during villous trophoblast differentiation. Sp
91  2004 YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation. NF-kappaB, TRAP, USF, YY1
92  2005 Activation of the insulin-like growth factor binding protein-5 promoter by parathyroid hormone in osteosarcoma cells requires activation of an activated protein-2 element. C/EBP, IGFBP-5, NF1, PTH
93  2005 Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks. AA, AP-1, cPLA2, LiCl, PKC
94  2005 Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. OT, OTase, P-LAP
95  2005 No apparent association between genetic polymorphisms (-102 C>T) and (-9 T>C) in the human manganese superoxide dismutase gene and gastric cancer(1). CI, MnSOD, OR
96  2005 Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. beta-MyHC, ET-1, MAPKs, ROS, Sp1
97  2005 Ultraviolet A-induced signaling involves a ceramide-mediated autocrine loop leading to ceramide de novo synthesis. ICAM-1, UVA
98  2005 Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. YY1
99  2005 [AP-2 expression and significance in the lung cancer tissues]. NSCLC
100  2006 A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. GCF2
101  2006 Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. HMGA1, IR
102  2006 Analysis of transcription factor AP-2 expression and function during mouse preimplantation development. ---
103  2006 Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens. GABAAR, NAc, PKA
104  2006 NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). FMRP, FXR1P, FXR2
105  2006 Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. AM, NF-IL6
106  2006 Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo. hSMVT, KLF4
107  2007 Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. ER, HER2
108  2007 Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. ---
109  2007 AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. ER, PCa
110  2007 Cloning, characterization and computational analysis of the 5' regulatory region of ovine glucose 6-phosphate dehydrogenase gene. G6PD, GATA, HNF-4, HSF, MEP, RAR, RFX, Sp1, SREBP, STRE, USF
111  2007 Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. MMP-9
112  2007 Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. STS, wtp53
113  2007 Salbutamol increases tristetraprolin expression in macrophages. 3'-UTR, AREs, GM-CSF, IBMX, NF-kappaB, PDEs, TNF-alpha, TTP
114  2007 Transcriptional regulation of the cholesterol side chain cleavage cytochrome P450 gene (CYP11A1) revisited: binding of GATA, cyclic adenosine 3',5'-monophosphate response element-binding protein and activating protein (AP)-1 proteins to a distal novel cluster of cis-regulatory elements potentiates AP-2 and steroidogenic factor-1-dependent gene expression in the rodent placenta and ovary. AP, CRE
115  2008 Cloning and functional characterization of the 5' regulatory region of ovine Hormone Sensitive Lipase (HSL) gene. 5'-UTR, ATGL, cAMP, CBFs, CRE, FSE, GR, GRE, HSL, IRE, ovHSL, PKA, Sp1
116  2008 Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells. PEA3, PKA, TAM, TAMR-MCF-7
117  2008 Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation. KOR, NGF
118  2008 Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. MnSOD, Sp1
119  2008 PKC-dependent stimulation of the human MCT1 promoter involves transcription factor AP2. SCFA
120  2008 SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2. MMP-2
121  2008 The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. siRNA, YY1
122  2008 The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. IR, PPARgamma, TZDs
123  2009 Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line. EVTs
124  2009 c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells. PKC
125  2009 Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells. AP-2gamma, ChIP
126  2009 Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines. ChIP, GST
127  2009 Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter. AP-2alpha, PDIP1, Sp1
128  2010 Dietary manganese modulates expression of the manganese-containing superoxide dismutase gene in chickens. Mn, MnSOD, MnSOD-BP, Sp1
129  2010 Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells. GO
130  2010 PACAP-regulated phenylethanolamine N-methyltransferase gene expression. PACAP, PNMT, Sp1
131  2010 Polymorphisms in the bovine lactoferrin promoter are associated with reproductive performance and somatic cell count. Sp1
132  2010 [Dual role of transcription factor AP-2 in carcinogenesis]. ---
133  2011 Transcription factor AP2 regulates human inhibin alpha subunit gene expression during in vitro trophoblast differentiation. ---
134  2012 AP-2beta regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes. AD, APOE, beta-AR
135  2012 Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics. AERD, ATA, DCBLD2, TFAP2A
136  2013 Ectopic expression of transcription factor AP-2delta in developing retina: effect on PSA-NCAM and axon routing. PSA-NCAM
137  2013 PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-beta precursor protein via a tissue-specific proximal regulatory element (PRE). AD, APP, EMSA, PRE, SNP, Sp1
138  2014 AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1. BMSCs, FZD1, hFOB
139  2014 Silencing of CHD5 gene by promoter methylation in leukemia. CHD5, DAC
140  2015 A Positive Feedback Loop between Glial Cells Missing 1 and Human Chorionic Gonadotropin (hCG) Regulates Placental hCGbeta Expression and Cell Differentiation. cAMP, GBS1, GCM1, hCG, PKA
141  2015 Analysis of genetic variations across regulatory and coding regions of kappa-casein gene of Indian native cattle (Bos indicus) and buffalo (Bubalus bubalis). kappa-CN, LD, PMF, TFBSs, TFs
142  2016 Epigenetic programming of Dnmt3a mediated by AP2alpha is required for granting preadipocyte the ability to differentiate. AP2alpha, CI
143  2016 Use of molecular biomarkers to estimate manganese requirements for broiler chickens from 22 to 42 d of age. MnSOD, Sp1
144  2018 Activator Protein-2beta Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer. ---
145  2018 Conditional Deletion of AP-2alpha and AP-2beta in the Developing Murine Retina Leads to Altered Amacrine Cell Mosaics and Disrupted Visual Function. ---
146  2018 Functional characterization of the Sox2, c-Myc, and Oct4 promoters. ---
147  2018 Kahweol inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. FASN, HER2, mTOR, PEA3, SREBP-1c
148  2018 TFAP2C regulates transcription in human naive pluripotency by opening enhancers. ---
149  2019 The biological characteristics of transcription factors AP-2alpha and AP-2gamma and their importance in various types of cancers. lncRNA, TF
150  2021 In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer. WWOX